Sign In

Login

Password

Forgot Password ? Sign Up

Fencamfamin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fencamfamin" in English language version.

refsWebsite
Global rank English rank
10doi.org
2nd place
2nd place
4nih.gov
4th place
4th place
3semanticscholar.org
11th place
8th place
2web.archive.org
1st place
1st place
1in.gov.br
3,151st place
5,932nd place
1espacenet.com
800th place
676th place
1intekom.com
low place
low place
1orgsyn.org
2,971st place
2,826th place

doi.org

  • Delbeke FT, Debackere M (1981). "Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion". Biopharmaceutics & Drug Disposition. 2 (1): 17–30. doi:10.1002/bdd.2510020103. PMID 7236868.
  • Seyfried CA (August 1983). "Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study". Biochemical Pharmacology. 32 (15): 2329–31. doi:10.1016/0006-2952(83)90181-8. PMID 6136281.
  • Planeta C, Aizenstein ML, DeLucia R (January 1995). "Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors". Pharmacology, Biochemistry, and Behavior. 50 (1): 35–40. doi:10.1016/0091-3057(94)00236-C. PMID 7700952. S2CID 9034041.
  • Agmo A, Federman I, Navarro V, Padua M, Velazquez G (September 1993). "Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes". Pharmacology, Biochemistry, and Behavior. 46 (1): 183–94. doi:10.1016/0091-3057(93)90339-u. PMID 8255911. S2CID 43900354.
  • Worrall DE (1929). "Nitrostyrene". Organic Syntheses. 9: 66. doi:10.15227/orgsyn.009.0066; Collected Volumes, vol. 1, p. 413.
  • Allen CF, Bell A (1939). "β-Nitrostyrene in the Diene Synthesis". J. Am. Chem. Soc. 61 (2): 521–522. doi:10.1021/ja01871a501.
  • Parham WE, Hunter WT, Hanson R (1951). "endo-5-Aminobicyclo [2,2,1]heptene-2". J. Am. Chem. Soc. 73 (11): 5068–5070. doi:10.1021/ja01155a013.
  • Novakov IA, Orlinson BS, Brunilin RV, Navrotskii MB, Eremiichuk AS, Dumler SA, Gordeeva EA (2011). "An improved synthesis of N-(3-phenylbicyclo[2.2.1]-yl)-N-ethylamine hydrochloride (Fencamfamine)". Pharm. Chem. J. 45 (7): 419–422. doi:10.1007/s11094-011-0646-3. S2CID 28946797.
  • Weinstock J, Schwartz N, Kormendy MF (1961). "Stereochemistry of a 3-Phenylnorbornane-2-amine". J. Org. Chem. 26 (12): 5247–5249. doi:10.1021/jo01070a540.
  • Poos GI, Kleis J, Wittekind RR, Rosenau JS (1961). "Bicyclic Bases. III. Isomeric 2-Amino-3-phenylnorbornanes". J. Org. Chem. 26 (12): 4898–4904. doi:10.1021/jo01070a029.

espacenet.com

worldwide.espacenet.com

  • DE patent 1110159, "Improvements in or relating to Amino-Norcamphane Compounds", issued 1961-07-06, assigned to Merck 

in.gov.br

  • Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

intekom.com

home.intekom.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Delbeke FT, Debackere M (1981). "Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion". Biopharmaceutics & Drug Disposition. 2 (1): 17–30. doi:10.1002/bdd.2510020103. PMID 7236868.
  • Seyfried CA (August 1983). "Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study". Biochemical Pharmacology. 32 (15): 2329–31. doi:10.1016/0006-2952(83)90181-8. PMID 6136281.
  • Planeta C, Aizenstein ML, DeLucia R (January 1995). "Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors". Pharmacology, Biochemistry, and Behavior. 50 (1): 35–40. doi:10.1016/0091-3057(94)00236-C. PMID 7700952. S2CID 9034041.
  • Agmo A, Federman I, Navarro V, Padua M, Velazquez G (September 1993). "Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes". Pharmacology, Biochemistry, and Behavior. 46 (1): 183–94. doi:10.1016/0091-3057(93)90339-u. PMID 8255911. S2CID 43900354.

orgsyn.org

semanticscholar.org

api.semanticscholar.org

  • Planeta C, Aizenstein ML, DeLucia R (January 1995). "Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors". Pharmacology, Biochemistry, and Behavior. 50 (1): 35–40. doi:10.1016/0091-3057(94)00236-C. PMID 7700952. S2CID 9034041.
  • Agmo A, Federman I, Navarro V, Padua M, Velazquez G (September 1993). "Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes". Pharmacology, Biochemistry, and Behavior. 46 (1): 183–94. doi:10.1016/0091-3057(93)90339-u. PMID 8255911. S2CID 43900354.
  • Novakov IA, Orlinson BS, Brunilin RV, Navrotskii MB, Eremiichuk AS, Dumler SA, Gordeeva EA (2011). "An improved synthesis of N-(3-phenylbicyclo[2.2.1]-yl)-N-ethylamine hydrochloride (Fencamfamine)". Pharm. Chem. J. 45 (7): 419–422. doi:10.1007/s11094-011-0646-3. S2CID 28946797.

web.archive.org

  • Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  • "REACTIVAN Tablets; REACTIVAN Syrup". Merck. Archived from the original on 2020-09-25. Retrieved 2007-01-23.